[go: up one dir, main page]

0% found this document useful (0 votes)
263 views4 pages

Clinical Pathway Dengue

This clinical pathway document provides guidance for treating patients with dengue fever over multiple days from admission through recovery. It outlines assessment factors, examinations, laboratory tests, treatments, nutrition/hydration protocols, mobility restrictions, and safety measures to be addressed on each day of fever and after fever subsides. Variances from the care path are to be documented. Comorbidities/risk factors and additional personnel details are also included.

Uploaded by

dr. Albertus S.A
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
263 views4 pages

Clinical Pathway Dengue

This clinical pathway document provides guidance for treating patients with dengue fever over multiple days from admission through recovery. It outlines assessment factors, examinations, laboratory tests, treatments, nutrition/hydration protocols, mobility restrictions, and safety measures to be addressed on each day of fever and after fever subsides. Variances from the care path are to be documented. Comorbidities/risk factors and additional personnel details are also included.

Uploaded by

dr. Albertus S.A
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 4

MR 44B

PATIENT STICKER

CLINICAL PATHWAY

DENGUE FEVER

Date ALLERGIES
Yes No
Department
Unknown

Please specify ALLERGY:


What Reaction:

DISCHARGE OUTCOMES ‐ To be completed before discharge

States support at home is adequate to meet their needs following discharge

Able to ambulate to optimum level

Demonstrates an understanding of post operative care

VARIANCE CODE LIST‐record any variations as a "X" on care path and document in integrated progress notes

1 PATIENT 2 INTERNAL SYSTEM 3 SOCIAL/COMMUNITY


1.A Vital sign/observation 2.A Unplanned cancellations 3.A Delay in transport availability
1.B Consult & Investigation 2.B Delay in Consultations 3.B Delay in home/community
1.C Pain Management 2.C Delay in Discharge Planning Family support
1.D Treatments 2.D Others 3.C Equipment/supplies not available
1.E Nutrition & Hydration 3.D Others
1.F Elimination
1.G Risk Assessments
1.H Mobility & Physical Therapy
1.I Hygiene & Skin Integrity
1.J Individual Needs
1.J Education & Discharge Need
1.K Feeding

ADDITIONAL NAMES, SIGNATURES, DESIGNATION AND INITIALS


COMORBIDITIES/RISK FACTORS
Print name Signature Designation Initials

ASTHMA

HYPERTENTION

DIABETES

CARDIOVASCULAR

OTHER

DESCRIBE
MR 44B
CLINICAL PATHWAY Please fill in with  if done
̶if not done
X if abnormalities found ‐ please document in integrated progress
DENGUE FEVER IN ADULT notes
N/A When not
Day Admission ‐ Fever Day Fever Day Fever Day
Date M A N M A N M A N
Program in accordance with Program in accordance with
1.A. Assessment 1 Complete medical assessment
doctor doctor
2 Complete nursing assessment
3 Vital sign every 6‐8 hrs, temp Vital sign every 6‐8 hrs, temp Vital sign every 6‐8 hrs, temp
every 4 hours or according to every 4 hours or according to every 4 hours or according to
the patient's condition the patient's condition the patient's condition
4 Assessment of consciousness Assessment of consciousness Assessment of consciousness
5 Monitoring sign of bleeding & Monitoring sign of bleeding & Monitoring sign of bleeding &
shock shock shock
6 Complete Falls Risk Complete Falls Risk Complete Falls Risk
7 Complete Braden Scale Complete Braden Scale Complete Braden Scale
8 Complete Phlebitis Scale Complete Phlebitis Scale Complete Phlebitis Scale
9 Complete VTE Risk Assessment Complete VTE Risk Assessment & Complete VTE Risk Assessment &
& contra indication for contra indication for prophylaxis contra indication for prophylaxis
prophylaxis medication medication medication
1.B. Consultation 1 Examination by GP Examination by GP Examination by GP
& examination 2 Examination by Specialist as Examination by Specialist as Examination by Specialist as
required required required
3 Lab examination: CBC,
Lab examination :CBC (as Lab examination :CBC (as
electrolyte, SC, BUN
instruction by doctor) instruction by doctor)
4 LFT (repeat every 3 days) Other: Other:
5 Ns1 antigen dengue
(Fever day 1‐3)
6 IgG, IgM dengue (Fever day 6)
1.C. Pain 1 Assess pain on vital signs chart, Assess pain on vital signs chart, Assess pain on vital signs chart,
Management analgesia as required. analgesia as required. analgesia as required.

IV therapy IV therapy IV therapy


1.D. Care & 1
treatment 2 Supportive medication Supportive medication Supportive medication
3 O Therapy as indicated
2
O Therapy as indicated
2
O Therapy as indicated
2

1.E. Nutrition & 1 Diet : not irritating food and Diet : not irritating food and Diet : not irritating food and
Hydration colored food colored food colored food
2 Observe for nausea & vomiting Observe for nausea & vomiting Observe for nausea & vomiting
3 Monitor intake, output every Monitor intake, output every Monitor intake, output every
shift and according doctor shift and according doctor shift and according doctor
instruction instruction instruction
4 Monitoring fluid balance Monitoring fluid balance Monitoring fluid balance
1.F. Elimination 1 Observation Bowel movement Observation Bowel movement Observation Bowel movement
1.G. Hygiene 1 Assist as required Assist as required Assist as required
1.H. Mobilization 1 Restrictions on activities Restrictions on activities Restrictions on activities
or Bed Rest if Thrombocyte or Bed Rest if Thrombocyte or Bed Rest if Thrombocyte
level ≤ 25.000 level ≤ 25.000 level ≤ 25.000
1.I. Patient safety 1 Bed rails attached Bed rails attached Bed rails attached
2 Lower bed position Lower bed position Lower bed position
3 Bell within reach patients Bell within reach patients Bell within reach patients
4 The floor is not slippery The floor is not slippery The floor is not slippery
1.J. Discharge 1 Orientation to ward Explanation of Condition Explanation of Condition
planning/ 2 Explanation of Condition Estimated Discharge Date Estimated Discharge Date
education 3 Estimated Discharge Date
Sign: Sign: Sign:
Reason: Reason: Reason:
MR 44B
CLINICAL PATHWAY Please fill in with  if done
̶if not done
X if abnormalities found ‐ please document in integrated progress notes
DENGUE FEVER IN ADULT N/A When not
applicaable
Day Fever Day Fever Day Fever Day
Date M A N M A N M A N
Program in accordance with Program in accordance with Program in accordance with
1.A. Assessment 1
doctor doctor doctor
2
3 Vital sign every 6‐8 hrs or Vital sign every 6‐8 hrs or Vital sign every 6‐8 hrs or
according to the patient's according to the patient's according to the patient's
condition condition condition
4 Assessment of consciousness Assessment of consciousness Assessment of consciousness
5 Monitoring sign of bleeding & Monitoring sign of bleeding & Monitoring sign of bleeding &
shock shock shock
6 Complete Falls Risk Complete Falls Risk Complete Falls Risk
7 Complete Braden Scale Complete Braden Scale Complete Braden Scale
8 Complete Phlebitis Scale Complete Phlebitis Scale Complete Phlebitis Scale
9 Complete VTE Risk Assessment Complete VTE Risk Assessment & Complete VTE Risk Assessment &
& contra indication for contra indication for prophylaxis contra indication for prophylaxis
prophylaxis medication medication medication
1.B. Consultation 1 Examination by GP Examination by GP Examination by GP
& examination 2 Examination by Specialist as Examination by Specialist as Examination by Specialist as
required required required
3 Lab examination :CBC (as Lab examination :CBC (as Lab examination :CBC (as
instruction by doctor) instruction by doctor) instruction by doctor)
4 Other: Other: Other:
5
6
1.C. Pain 7 Assess pain on vital signs chart, Assess pain on vital signs chart, Assess pain on vital signs chart,
Management analgesia as required. analgesia as required. analgesia as required.

IV therapy IV therapy IV therapy


1.D. Care & 1
2 Resite IV Cannula
treatment
3 Supportive medication Supportive medication Supportive medication
4 O Therapy as indicated
2
O Therapy as indicated
2
O Therapy as indicated
2

1.E. Nutrition & 1 Diet : not irritating food and Diet : not irritating food and Diet : not irritating food and
Hydration colored food colored food colored food
2 Observe for nausea & vomiting Observe for nausea & vomiting Observe for nausea & vomiting
3 Monitor intake, output every Monitor intake, output every Monitor intake, output every
shift and according doctor shift and according doctor shift and according doctor
instruction instruction instruction
4 Monitoring fluid balance Monitoring fluid balance Monitoring fluid balance
1.F. Elimination 1 Observation Bowel movement Observation Bowel movement Observation Bowel movement
1.G. Hygiene 1 Assist as required Assist as required Assist as required
1.H. Mobilization 1 Restrictions on activities Restrictions on activities Restrictions on activities
or Bed Rest if Thrombocyte or Bed Rest if Thrombocyte or Bed Rest if Thrombocyte
level ≤ 25.000 level ≤ 25.000 level ≤ 25.000
1.I. Patient safety 1 Bed rails attached Bed rails attached Bed rails attached
2 Lower bed position Lower bed position Lower bed position
3 Bell within reach patients Bell within reach patients Bell within reach patients
4 The floor is not slippery The floor is not slippery The floor is not slippery
1.J. Discharge 1 Explanation of Condition Explanation of Condition Explanation of Condition
2 Estimated Discharge Date Estimated Discharge Date Estimated Discharge Date
planning/
3 Upon discharge discuss Upon discharge discuss Upon discharge discuss
education eradication of mosquito eradication of mosquito eradication of mosquito
patient breeding. Use of personal breeding. Use of personal breeding. Use of personal
mosquito repellant, room spray, mosquito repellant, room spray, mosquito repellant, room spray,
net. net. net.
Sign: Sign: Sign:
Reason: Reason: Reason:
MR 44B
CLINICAL PATHWAY Please fill in with  if done
̶if not done
X if abnormalities found ‐ please document in integrated progress notes
DENGUE FEVER IN ADULT N/A When not
applicaable
Day Fever Day Fever Day Fever Day
Date M A N M A N M A N
Program in accordance with Program in accordance with Program in accordance with
1.A. Assessment 1
doctor doctor doctor
2
3 Vital sign every 6‐8 hrs or Vital sign every 6‐8 hrs or Vital sign every 6‐8 hrs or
according to the patient's according to the patient's according to the patient's
condition condition condition
4 Assessment of consciousness Assessment of consciousness Assessment of consciousness
5 Monitoring sign of bleeding & Monitoring sign of bleeding & Monitoring sign of bleeding &
shock shock shock
6 Complete Falls Risk Complete Falls Risk Complete Falls Risk
7 Complete Braden Scale Complete Braden Scale Complete Braden Scale
8 Complete Phlebitis Scale Complete Phlebitis Scale Complete Phlebitis Scale
9 Complete VTE Risk Assessment Complete VTE Risk Assessment & Complete VTE Risk Assessment &
& contra indication for contra indication for prophylaxis contra indication for prophylaxis
prophylaxis medication medication medication
1.B. Consultation 1 Examination by GP Examination by GP Examination by GP
& examination 2 Examination by Specialist as Examination by Specialist as Examination by Specialist as
required required required
3 Lab examination :CBC (as Lab examination :CBC (as Lab examination :CBC (as
instruction by doctor) instruction by doctor) instruction by doctor)
4 Other: Other: Other:
5
6
1.C. Pain 1 Assess pain on vital signs chart, Assess pain on vital signs chart, Assess pain on vital signs chart,
Management analgesia as required. analgesia as required. analgesia as required.

IV therapy IV therapy IV therapy


1.D. Care & 1
treatment 2 Resite IV Cannula
3 Supportive medication Supportive medication Supportive medication
1 O Therapy as indicated
2
O Therapy as indicated
2
O Therapy as indicated
2

1.E. Nutrition & 2 Diet : not irritating food and Diet : not irritating food and Diet : not irritating food and
Hydration colored food colored food colored food
3 Observe for nausea & vomiting Observe for nausea & vomiting Observe for nausea & vomiting
4 Monitor intake, output every Monitor intake, output every Monitor intake, output every
shift and according doctor shift and according doctor shift and according doctor
instruction instruction instruction
1 Monitoring fluid balance Monitoring fluid balance Monitoring fluid balance
1.F. Elimination 2 Observation Bowel movement Observation Bowel movement Observation Bowel movement
1.G. Hygiene 3 Assist as required Assist as required Assist as required
1.H. Mobilization 1 Restrictions on activities Restrictions on activities Restrictions on activities
or Bed Rest if Thrombocyte or Bed Rest if Thrombocyte or Bed Rest if Thrombocyte
level ≤ 25.000 level ≤ 25.000 level ≤ 25.000
1.I. Patient safety 1 Bed rails attached Bed rails attached Bed rails attached
2 Lower bed position Lower bed position Lower bed position
3 Bell within reach patients Bell within reach patients Bell within reach patients
4 The floor is not slippery The floor is not slippery The floor is not slippery
1.J. Discharge 1 Explanation of Condition Explanation of Condition Explanation of Condition
2 Estimated Discharge Date Estimated Discharge Date Estimated Discharge Date
planning/
3 Upon discharge discuss Upon discharge discuss Upon discharge discuss
education eradication of mosquito eradication of mosquito eradication of mosquito
patient breeding. Use of personal breeding. Use of personal breeding. Use of personal
mosquito repellant, room spray, mosquito repellant, room spray, mosquito repellant, room spray,
net. net. net.
Sign: Sign: Sign:
Reason: Reason: Reason:

You might also like